Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration

To assess pharmacodynamic responses to ranibizumab, an inhibitor of vascular endothelial growth factor A (VEGF-A), in a study of the treatment of minimally classic or occult with no classic choroidal neovascularization secondary to age-related macular degeneration (AMD) (designated MARINA [Minimally...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Ophthalmology (Rochester, Minn.) Ročník 114; číslo 10; s. 1868
Hlavní autori:	Kaiser, Peter K, Blodi, Barbara A, Shapiro, Howard, Acharya, Nisha R
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.10.2007
Predmet:	Aged Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - pharmacology Antibodies, Monoclonal, Humanized Choroidal Neovascularization - diagnosis Choroidal Neovascularization - drug therapy Double-Blind Method Female Fluorescein Angiography Humans Injections Macular Degeneration - diagnosis Macular Degeneration - drug therapy Male Ranibizumab Retrospective Studies Tomography, Optical Coherence Treatment Outcome Vascular Endothelial Growth Factor A - antagonists & inhibitors Visual Acuity - drug effects Vitreous Body
ISSN:	1549-4713, 1549-4713
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!